Bicycle Therapeutics (ADR) (BCYC)
Develops Bicycle Drug Conjugates and radioconjugates for precision oncology.
$4.30
At close+0.20 (+4.88%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions103 holders · as of Mar 31, 2026 | 107.04% | 74.92M ADS | |
| Insiders21 holders · as of Jul 7, 2026 | 4.50% | 3.15M ADS | |
| Adds to | 111.54% |
69.99M ADS as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 111.54%; nothing is left for Other.
This company has 2 share classes; every stake here is a share of the whole company.
Institutions13F, as of Mar 31, 2026
103 holders · 37.46M shares · 15 new positions · 58 increased · 16 reduced · 27 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 10.89M | 15.55% | 0 | May 15, 2026 |
| FCPM Iii Services B.V. | 3.47M | 4.96% | 0 | May 15, 2026 |
| Armistice Capital, LLC | 3.40M | 4.85% | +162.0K | May 15, 2026 |
| Long Focus Capital Management, LLC | 3.31M | 4.73% | +1.68M | May 15, 2026 |
| Acadian Asset Management LLC | 1.97M | 2.81% | +296.8K | May 13, 2026 |
| Siren, L.L.C. | 1.56M | 2.23% | −451.9K | May 14, 2026 |
| GSK PLC | 1.53M | 2.19% | 0 | May 14, 2026 |
| Principal Financial Group Inc | 1.17M | 1.68% | +26.4K | May 4, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 6.75% | 3.40M | 13G | May 15, 2026 ↗ |
| Long Focus Capital Management, LLC | 6.60% | 3.31M | 13G | May 15, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 6, 2026 | Travis Alvin Thompsonofficer: Chief Financial Officer | Sale | 104 | $4.31 | 64,441 |
| Jul 2, 2026 | Travis Alvin Thompsonofficer: Chief Financial Officer | Sale | 819 | $4.27 | 64,545 |
| Jul 6, 2026 | Michael Charles Ferguson Hannayofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 255 | $4.31 | 94,375 |
| Jul 2, 2026 | Michael Charles Ferguson Hannayofficer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1,506 | $4.27 | 94,630 |
| Jul 6, 2026 | Kevin Leedirector, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,737 | $4.31 | 603,671 |
| Jul 2, 2026 | Kevin Leedirector, officer: CHIEF EXECUTIVE OFFICER | Sale | 5,905 | $4.27 | 605,408 |
| Jul 6, 2026 | Michael Skynnerofficer: CHIEF SCIENTIFIC OFFICER | Sale | 532 | $4.31 | 157,171 |
| Jul 2, 2026 | Michael Skynnerofficer: CHIEF SCIENTIFIC OFFICER | Sale | 1,859 | $4.27 | 157,703 |
| Jul 6, 2026 | Jennifer Scott Perryofficer: Chief Operating Officer | Sale · 2 lots | 376 | $4.34 | 91,052 |
| Jul 2, 2026 | Jennifer Scott Perryofficer: Chief Operating Officer | Sale | 1,036 | $4.27 | 91,428 |
CongressHouse and Senate disclosures
Not reported.